The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Complete Response to Neoadjuvant Chemoradiotherapy in Esophageal Carcinoma Is Associated With Significantly Improved Survival
Abstract
Purpose: Attempts to improve survival of patients with esophageal cancer have been made using induction chemoradiotherapy (CRT) followed by surgery. A large single-center experience was reviewed to determine which treatment-related variables could predict survival and recurrence. Patients and Methods: All patients undergoing esophagectomy between January 1994 and December 2002 were reviewed. Univariate and multivariate analyses were performed using log-rank and Cox proportional hazards models, and survival curves were estimated using the Kaplan-Meier method. Results: Of 171 patients with invasive cancer, 131 (77%) underwent preoperative CRT. The average age was 60 years, and most patients were male (85%). Operations performed included Ivor-Lewis (60%), transhiatal (8%), three-hole (23%), or left thoracoabdominal (8%) esophagectomy. Perioperative mortality rate was 5%. Median overall survival (OS) of the entire group was 33 months, and the 5-year OS rate was 26%. Induction CRT was associated with a 33% 5-year survival rate compared with 11% for surgery alone (P = .43). Patients downstaged to pathologic stage 0 or I had an improved OS and disease-free survival (DFS) compared with those patients who were not downstaged (P = .022). Additionally, the ability to perform an R0 resection was a significant factor for OS and DFS (n = 130; P < .0001 and P <.0002, respectively). Conclusion: Response to CRT and the ability to perform an R0 resection are associated with significantly improved survival in patients with esophageal carcinoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Murray, T., Samuels, A., Ghafoor, A., Ward, E., & Thun, M. J. (2003) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.53.1.5 · Cited by 3,275
Herskovic, A., Martz, K., Al-Sarraf, M., Leichman, L., Brindle, J., Vaitkevicius, V., Cooper, J., Byhardt, R., Davis, L., & Emami, B. (1992) · New England Journal of Medicine · doi:10.1056/nejm199206113262403 · Cited by 2,108
A Comparison of Multimodal Therapy and Surgery for Esophageal Adenocarcinoma
Walsh, T. N., Noonan, N., Hollywood, D., Kelly, A., Keeling, N., & Hennessy, T. P. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608153350702 · Cited by 1,950
Bosset, J.-F., Gignoux, M., Triboulet, J.-P., Tiret, E., Mantion, G., Elias, D., Lozach, P., Ollier, J.-C., Pavy, J.-J., Mercier, M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707173370304 · Cited by 1,376
Urba, S. G., Orringer, M. B., Turrisi, A., Iannettoni, M., Forastiere, A., & Strawderman, M. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.305 · Cited by 1,266
al-Sarraf, M., Martz, K., Herskovic, A., Leichman, L., Brindle, J. S., Vaitkevicius, V. K., Cooper, J., Byhardt, R., Davis, L., & Emami, B. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.1.277 · Cited by 739
Prise, E. L., Etienne, P. L., Meunier, B., Maddern, G., Hassel, M. B., Gedouin, D., Boutin, D., Campion, J. P., & Launois, B. (1994) · Cancer · doi:10.1002/1097-0142(19940401)73:7<1779::aid-cncr2820730702>3.0.co;2-t · Cited by 617
Nygaard, K., Hagen, S., Hansen, H. S., Hatlevoll, R., Hultborn, R., Jakobsen, A., Mäntyla, M., Modig, H., Munck‐Wikland, E., Rosengren, B., et al. (1992) · World Journal of Surgery · doi:10.1007/bf02067069 · Cited by 615
Flamen, P., Van Cutsem, E., Lerut, A., Cambier, J.-P., Haustermans, K., Bormans, G., De Leyn, P., Van Raemdonck, D., De Wever, W., Ectors, N., et al. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf081 · Cited by 341
Downey, R. J., Akhurst, T., Ilson, D., Ginsberg, R., Bains, M. S., Gonen, M., Koong, H., Gollub, M., Minsky, B. D., Zakowski, M., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.013 · Cited by 320
Cited by
Menzies, A. M., Amaria, R. N., Rozeman, E. A., Huang, A. C., Tetzlaff, M. T., van de Wiel, B. A., Lo, S., Tarhini, A. A., Burton, E. M., Pennington, T. E., et al. (2021) · Nature Medicine · doi:10.1038/s41591-020-01188-3 · Cited by 436
Ajani, J. A., Winter, K., Okawara, G. S., Donohue, J. H., Pisters, P. W. T., Crane, C. H., Greskovich, J. F., Anne, P. R., Bradley, J. D., Willett, C., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.4840 · Cited by 385
Li, C., Zhao, S., Zheng, Y., Han, Y., Chen, X., Cheng, Z., Wu, Y., Feng, X., Qi, W., Chen, K., et al. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2020.11.039 · Cited by 324
Clinical development of new drug–radiotherapy combinations
on behalf of the NCRI CTRad Academia-Pharma Joint Working Group, Sharma, R. A., Plummer, R., Stock, J. K., Greenhalgh, T. A., Ataman, O., Kelly, S., Clay, R., Adams, R. A., Baird, R. D., et al. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.79 · Cited by 320
Reporting of Short-Term Clinical Outcomes After Esophagectomy: A Systematic Review
Blencowe, N. S., Strong, S., McNair, A. G. K., Brookes, S. T., Crosby, T., Griffin, S. M., & Blazeby, J. M. (2012) · Annals of Surgery · doi:10.1097/sla.0b013e3182480a6a · Cited by 292
Metadata
- Authors
- Berger, A. C., Farma, J., Scott, W. J., Freedman, G., Weiner, L., Cheng, J. D., Wang, H., & Goldberg, M.
- Venue
- Journal of Clinical Oncology
- Published
- 2005-07-01
- Volume
- 23
- Issue
- 19
- Pages
- 4330-4337
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2136935697
- Cited by
- 505
- References
- 14
- FWCI
- 22.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Complete Response to Neoadjuvant Chemoradiotherapy in Esophageal Carcinoma Is Associated With Significantly Improved Survival. https://app.cochat.ai/papers/10.1200/jco.2005.05.017
- The paper
- Berger, A. C., Farma, J., Scott, W. J., Freedman, G., Weiner, L., Cheng, J. D., Wang, H., & Goldberg, M. (2005). Complete Response to Neoadjuvant Chemoradiotherapy in Esophageal Carcinoma Is Associated With Significantly Improved Survival. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2005.05.017
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.